Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance

Research article (Frontiers in Drug Safety and Regulation, 2022) · cited 38× · AI/ML
Press Enter · cited answer in seconds

Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance

Summary

Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance is a scholarly article[1].

Key Facts

  • Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance's instance of is recorded as scholarly article[2].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance. Retrieved May 24, 2026, from https://4ort.xyz/entity/digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance
MLA “Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance.
BibTeX @misc{4ortxyz_digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance}}, year = {2026}, url = {https://4ort.xyz/entity/digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance — https://4ort.xyz/entity/digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/digital-therapeutics-in-perspective-from-regulatory-challenges-to-post-marketing-surveillance · Last refreshed: